The Lick-Carnegie Survey: Four New Exoplanet Candidates

We present new precise HIRES radial velocity (RV) data sets of five nearby stars obtained at Keck Observatory. HD 31253, HD 218566, HD 177830, HD 99492 and HD 74156 are host stars of spectral classes F through K and show radial velocity variations consistent with new or additional planetary companions in Keplerian motion. The orbital parameters of the candidate planets in the five planetary systems span minimum masses of M sin i = 27.43 M_{earth} to M sin i = 8.28 M_{jup}, periods of 17.05 to 4696.95 days and eccentricities ranging from circular to extremely eccentric (e ~ 0.63). The 5th star, HD 74156, was known to have both a 52-day and a 2500-day planet, and was claimed to also harbor a 3rd planet at 336d, in apparent support of the "Packed Planetary System" hypothesis. Our greatly expanded data set for HD 74156 provides strong confirmation of both the 52-day and 2500-d planets, but strongly contradicts the existence of a 336-day planet, and offers no significant evidence for any other planets in the system.Comment: 13 pages, 15 figures. Accepted for publication in ApJ. Fixed typos in Table 2. Additional material at http://www.ucolick.org/~smeschia/4planet.ph

Debris Disks of Members of the Blanco 1 Open Cluster

We have used the Spitzer Space Telescope to obtain Multiband Imaging Photometer for Spitzer (MIPS) 24 um photometry for 37 members of the ~100 Myr old open cluster Blanco 1. For the brightest 25 of these stars (where we have 3sigma uncertainties less than 15%), we find significant mid-IR excesses for eight stars, corresponding to a debris disk detection frequency of about 32%. The stars with excesses include two A stars, four F dwarfs and two G dwarfs. The most significant linkage between 24 um excess and any other stellar property for our Blanco 1 sample of stars is with binarity. Blanco 1 members that are photometric binaries show few or no detected 24 um excesses whereas a quarter of the apparently single Blanco 1 members do have excesses. We have examined the MIPS data for two other clusters of similar age to Blanco 1 -- NGC 2547 and the Pleiades. The AFGK photometric binary star members of both of these clusters also show a much lower frequency of 24 um excesses compared to stars that lie near the single-star main sequence. We provide a new determination of the relation between V-Ks color and Ks-[24] color for main sequence photospheres based on Hyades members observed with MIPS. As a result of our analysis of the Hyades data, we identify three low mass Hyades members as candidates for having debris disks near the MIPS detection limit.Comment: Accepted to Ap

Mosquito saliva enhances virus infection through sialokinin-dependent vascular leakage

Viruses transmitted by Aedes mosquitoes are an increasingly important global cause of disease. Defining common determinants of host susceptibility to this large group of het-erogenous pathogens is key for informing the rational design of panviral medicines. Infection of the vertebrate host with these viruses is enhanced by mosquito saliva, a complex mixture of salivary-gland-derived factors and microbiota. We show that the enhancement of infection by saliva was dependent on vascular function and was independent of most antisaliva immune responses, including salivary microbiota. Instead, the Aedes gene product sialokinin mediated the enhancement of virus infection through a rapid reduction in endothelial barrier integrity. Sialokinin is unique within the insect world as having a vertebrate-like tachykinin sequence and is absent from Anopheles mosquitoes, which are incompetent for most arthropod-borne viruses, whose saliva was not proviral and did not induce similar vascular permeability. Therapeutic strategies targeting sialokinin have the potential to limit disease severity following infection with Aedes mosquito-borne viruses.</p

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide pandemic causing substantial morbidity, mortality, and economic devastation. In response, many laboratories have redirected attention to SARS-CoV-2, meaning there is an urgent need for tools that can be used in laboratories unaccustomed to working with coronaviruses. Here we report a range of tools for SARS-CoV-2 research. First, we describe a facile single plasmid SARS-CoV-2 reverse genetics system that is simple to genetically manipulate and can be used to rescue infectious virus through transient transfection (without in vitro transcription or additional expression plasmids). The rescue system is accompanied by our panel of SARS-CoV-2 antibodies (against nearly every viral protein), SARS-CoV-2 clinical isolates, and SARS-CoV-2 permissive cell lines, which are all openly available to the scientific community. Using these tools, we demonstrate here that the controversial ORF10 protein is expressed in infected cells. Furthermore, we show that the promising repurposed antiviral activity of apilimod is dependent on TMPRSS2 expression. Altogether, our SARS-CoV-2 toolkit, which can be directly accessed via our website at https://mrcppu-covid.bio/, constitutes a resource with considerable potential to advance COVID-19 vaccine design, drug testing, and discovery science

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Targeted application of topical innate immune agonists as a putative measure against arbovirus infection

No abstract available

Extending Graph Based Evolutionary Algorithms with Novel Graphs

Graph Based Evolutionary Algorithms (GBEAs) are a novel modification to the local mating rules of an evolutionary algorithm that allow for the control of diversity loss by restricting mating choices. Graph structures are used to impose an artificial geography on the solution set to mimic geographical boundaries and other mating retrictions found in nature. Previous work has shown that by using graphs of a lower degree, diversity in the population dereases at a slower rate, allowing for the formation of more diverse set of good building blocks. This research also indicated that graph degree is not the only factor affecting diversity preservation; different graphs with the same degree hinted at other factors that could influence information flow. In this paper, we investigate the effect of broadening the number of candidate graphs by introducing two new sets of graphs, one constructed from regular sub-graphs and one set constructed using geographic data from six locations in the United States. It was found that the use of sub-graphs connected to a central hub can promote the development of necesary building blocks and increasing performance for certain problems. In addition, it was shown that graphs with moderate to high level of diversity preservation are analogous to some geographic features in nature, providing a method to validate graphs used in epidemiological studies